Industry: Chemical & Material
Published Date: 2025-03-10
Pages: 120 Pages
Report ld: 4513584
Request Sample
Customized Report
Bifidobacterium Longum Subsp. Infantis M-63 Market Size(US$)

CAGR 2025-2031
6.2%
Market Size,2031
USD 67.7
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Bifidobacterium Longum Subsp. Infantis M-63 was valued at US$ 44.7 million in the year 2024 and is projected to reach a revised size of US$ 67.7 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
North American market for Bifidobacterium Longum Subsp. Infantis M-63 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bifidobacterium Longum Subsp. Infantis M-63 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Bifidobacterium Longum Subsp. Infantis M-63 include Mitushi Biopharma, Fengchen Group, Jiangsu Wecare Biotechnology Co., Ltd., Shenzhen Lefu Biotechnology Co., Ltd., Hebei Hongtao Bioengineering Co., Ltd., Shandong Junle Biotechnology Co., Ltd., Shandong Xinxiong Biotechnology Co., Ltd., Newgen Biotech, Pharm-Rx, Rajvi Enterprise, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Bifidobacterium Longum Subsp. Infantis M-63, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bifidobacterium Longum Subsp. Infantis M-63.
The Bifidobacterium Longum Subsp. Infantis M-63 market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bifidobacterium Longum Subsp. Infantis M-63 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bifidobacterium Longum Subsp. Infantis M-63 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bifidobacterium Longum Subsp. Infantis M-63 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bifidobacterium Longum Subsp. Infantis M-63 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bifidobacterium Longum Subsp. Infantis M-63 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Bifidobacterium Longum Subsp. Infantis M-63 Market Overview
1.1 Product Definition
1.2 Bifidobacterium Longum Subsp. Infantis M-63 by Type
1.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 0-50 billion CFU/g
1.2.3 50-100 billion CFU/g
1.2.4 >100 billion CFU/g
1.3 Bifidobacterium Longum Subsp. Infantis M-63 by Application
1.3.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Food Additives
1.3.3 Medicines and Supplements
1.3.4 Feed Additives
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Estimates and Forecasts (2020-2031)
1.4.4 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Market Share by Manufacturers (2020-2025)
2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Bifidobacterium Longum Subsp. Infantis M-63, Industry Ranking, 2023 VS 2024
2.4 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Bifidobacterium Longum Subsp. Infantis M-63, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Bifidobacterium Longum Subsp. Infantis M-63, Product Offered and Application
2.8 Global Key Manufacturers of Bifidobacterium Longum Subsp. Infantis M-63, Date of Enter into This Industry
2.9 Bifidobacterium Longum Subsp. Infantis M-63 Market Competitive Situation and Trends
2.9.1 Bifidobacterium Longum Subsp. Infantis M-63 Market Concentration Rate
2.9.2 Global 5 and 10 Largest Bifidobacterium Longum Subsp. Infantis M-63 Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Bifidobacterium Longum Subsp. Infantis M-63 Production by Region
3.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value by Region (2020-2031)
3.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Bifidobacterium Longum Subsp. Infantis M-63 by Region (2026-2031)
3.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Volume by Region (2020-2031)
3.4.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Bifidobacterium Longum Subsp. Infantis M-63 by Region (2026-2031)
3.5 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Price Analysis by Region (2020-2025)
3.6 Global Bifidobacterium Longum Subsp. Infantis M-63 Production and Value, Year-over-Year Growth
3.6.1 North America Bifidobacterium Longum Subsp. Infantis M-63 Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Bifidobacterium Longum Subsp. Infantis M-63 Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Bifidobacterium Longum Subsp. Infantis M-63 Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Bifidobacterium Longum Subsp. Infantis M-63 Production Value Estimates and Forecasts (2020-2031)
4 Bifidobacterium Longum Subsp. Infantis M-63 Consumption by Region
4.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Consumption by Region (2020-2031)
4.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Consumption by Region (2020-2025)
4.2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Bifidobacterium Longum Subsp. Infantis M-63 Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Bifidobacterium Longum Subsp. Infantis M-63 Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Bifidobacterium Longum Subsp. Infantis M-63 Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Bifidobacterium Longum Subsp. Infantis M-63 Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Bifidobacterium Longum Subsp. Infantis M-63 Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Bifidobacterium Longum Subsp. Infantis M-63 Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Production by Type (2020-2031)
5.1.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Production by Type (2020-2025)
5.1.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Production by Type (2026-2031)
5.1.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Market Share by Type (2020-2031)
5.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value by Type (2020-2031)
5.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value by Type (2020-2025)
5.2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value by Type (2026-2031)
5.2.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value Market Share by Type (2020-2031)
5.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Type (2020-2031)
6 Segment by Application
6.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Production by Application (2020-2031)
6.1.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Production by Application (2020-2025)
6.1.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Production by Application (2026-2031)
6.1.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Market Share by Application (2020-2031)
6.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value by Application (2020-2031)
6.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value by Application (2020-2025)
6.2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value by Application (2026-2031)
6.2.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Production Value Market Share by Application (2020-2031)
6.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Mitushi Biopharma
7.1.1 Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.1.2 Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.1.3 Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Mitushi Biopharma Main Business and Markets Served
7.1.5 Mitushi Biopharma Recent Developments/Updates
7.2 Fengchen Group
7.2.1 Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.2.2 Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.2.3 Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Fengchen Group Main Business and Markets Served
7.2.5 Fengchen Group Recent Developments/Updates
7.3 Jiangsu Wecare Biotechnology Co., Ltd.
7.3.1 Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.3.2 Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.3.3 Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Jiangsu Wecare Biotechnology Co., Ltd. Main Business and Markets Served
7.3.5 Jiangsu Wecare Biotechnology Co., Ltd. Recent Developments/Updates
7.4 Shenzhen Lefu Biotechnology Co., Ltd.
7.4.1 Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.4.2 Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.4.3 Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Shenzhen Lefu Biotechnology Co., Ltd. Main Business and Markets Served
7.4.5 Shenzhen Lefu Biotechnology Co., Ltd. Recent Developments/Updates
7.5 Hebei Hongtao Bioengineering Co., Ltd.
7.5.1 Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.5.2 Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.5.3 Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Hebei Hongtao Bioengineering Co., Ltd. Main Business and Markets Served
7.5.5 Hebei Hongtao Bioengineering Co., Ltd. Recent Developments/Updates
7.6 Shandong Junle Biotechnology Co., Ltd.
7.6.1 Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.6.2 Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.6.3 Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Shandong Junle Biotechnology Co., Ltd. Main Business and Markets Served
7.6.5 Shandong Junle Biotechnology Co., Ltd. Recent Developments/Updates
7.7 Shandong Xinxiong Biotechnology Co., Ltd.
7.7.1 Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.7.2 Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.7.3 Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Shandong Xinxiong Biotechnology Co., Ltd. Main Business and Markets Served
7.7.5 Shandong Xinxiong Biotechnology Co., Ltd. Recent Developments/Updates
7.8 Newgen Biotech
7.8.1 Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.8.2 Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.8.3 Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Newgen Biotech Main Business and Markets Served
7.8.5 Newgen Biotech Recent Developments/Updates
7.9 Pharm-Rx
7.9.1 Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.9.2 Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.9.3 Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Pharm-Rx Main Business and Markets Served
7.9.5 Pharm-Rx Recent Developments/Updates
7.10 Rajvi Enterprise
7.10.1 Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.10.2 Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.10.3 Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Rajvi Enterprise Main Business and Markets Served
7.10.5 Rajvi Enterprise Recent Developments/Updates
7.11 Shandong Pingao Pharmaceutical Co., Ltd.
7.11.1 Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.11.2 Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.11.3 Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Shandong Pingao Pharmaceutical Co., Ltd. Main Business and Markets Served
7.11.5 Shandong Pingao Pharmaceutical Co., Ltd. Recent Developments/Updates
7.12 Shaanxi Chenming Biotechnology Co., Ltd.
7.12.1 Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.12.2 Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.12.3 Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Shaanxi Chenming Biotechnology Co., Ltd. Main Business and Markets Served
7.12.5 Shaanxi Chenming Biotechnology Co., Ltd. Recent Developments/Updates
7.13 Xi'an Minglang Biotechnology Co., Ltd.
7.13.1 Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.13.2 Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.13.3 Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Xi'an Minglang Biotechnology Co., Ltd. Main Business and Markets Served
7.13.5 Xi'an Minglang Biotechnology Co., Ltd. Recent Developments/Updates
7.14 Jiahe Biotechnology (Shanxi) Co., Ltd.
7.14.1 Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.14.2 Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.14.3 Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Jiahe Biotechnology (Shanxi) Co., Ltd. Main Business and Markets Served
7.14.5 Jiahe Biotechnology (Shanxi) Co., Ltd. Recent Developments/Updates
7.15 Shaanxi Ruimao Biotechnology Co., Ltd.
7.15.1 Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.15.2 Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.15.3 Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Shaanxi Ruimao Biotechnology Co., Ltd. Main Business and Markets Served
7.15.5 Shaanxi Ruimao Biotechnology Co., Ltd. Recent Developments/Updates
7.16 Shaanxi Baohe Biotechnology Co., Ltd.
7.16.1 Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.16.2 Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.16.3 Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Shaanxi Baohe Biotechnology Co., Ltd. Main Business and Markets Served
7.16.5 Shaanxi Baohe Biotechnology Co., Ltd. Recent Developments/Updates
7.17 Shaanxi Lesent Biotechnology Co., Ltd.
7.17.1 Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.17.2 Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.17.3 Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Shaanxi Lesent Biotechnology Co., Ltd. Main Business and Markets Served
7.17.5 Shaanxi Lesent Biotechnology Co., Ltd. Recent Developments/Updates
7.18 Shaanxi Shuoyang Biotechnology Co., Ltd.
7.18.1 Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.18.2 Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.18.3 Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.18.4 Shaanxi Shuoyang Biotechnology Co., Ltd. Main Business and Markets Served
7.18.5 Shaanxi Shuoyang Biotechnology Co., Ltd. Recent Developments/Updates
7.19 Shaanxi Mufan Biotechnology Co., Ltd.
7.19.1 Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.19.2 Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.19.3 Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.19.4 Shaanxi Mufan Biotechnology Co., Ltd. Main Business and Markets Served
7.19.5 Shaanxi Mufan Biotechnology Co., Ltd. Recent Developments/Updates
7.20 Xi'an An'Drong Biomedical Technology Co., Ltd.
7.20.1 Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.20.2 Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.20.3 Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.20.4 Xi'an An'Drong Biomedical Technology Co., Ltd. Main Business and Markets Served
7.20.5 Xi'an An'Drong Biomedical Technology Co., Ltd. Recent Developments/Updates
7.21 Shaanxi Guanchen Biotechnology Co., Ltd.
7.21.1 Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Company Information
7.21.2 Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product Portfolio
7.21.3 Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Production, Value, Price and Gross Margin (2020-2025)
7.21.4 Shaanxi Guanchen Biotechnology Co., Ltd. Main Business and Markets Served
7.21.5 Shaanxi Guanchen Biotechnology Co., Ltd. Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Bifidobacterium Longum Subsp. Infantis M-63 Industry Chain Analysis
8.2 Bifidobacterium Longum Subsp. Infantis M-63 Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Bifidobacterium Longum Subsp. Infantis M-63 Production Mode & Process Analysis
8.4 Bifidobacterium Longum Subsp. Infantis M-63 Sales and Marketing
8.4.1 Bifidobacterium Longum Subsp. Infantis M-63 Sales Channels
8.4.2 Bifidobacterium Longum Subsp. Infantis M-63 Distributors
8.5 Bifidobacterium Longum Subsp. Infantis M-63 Customer Analysis
9 Bifidobacterium Longum Subsp. Infantis M-63 Market Dynamics
9.1 Bifidobacterium Longum Subsp. Infantis M-63 Industry Trends
9.2 Bifidobacterium Longum Subsp. Infantis M-63 Market Drivers
9.3 Bifidobacterium Longum Subsp. Infantis M-63 Market Challenges
9.4 Bifidobacterium Longum Subsp. Infantis M-63 Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Bifidobacterium Longum Subsp. Infantis M-63 market is projected to grow from US$ 47.19 million in 2025 to US$ 71.49 million by 2032, at a CAGR of 6.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 200
USD 4900.00
(Single User License)
The global Bifidobacterium Longum Subsp. Infantis M-63 market size was US$ 47.19 million in 2025 and is forecast to reach a readjusted size of US$ 71.49 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 115
USD 4250.00
(Single User License)
The global market for Bifidobacterium Longum Subsp. Infantis M-63 was estimated to be worth US$ 47.19 million in 2025 and is projected to reach US$ 71.49 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 154
USD 3950.00
(Single User License)
The global Bifidobacterium Longum Subsp. Infantis M-63 market was valued at US$ 47.19 million in 2025 and is anticipated to reach US$ 71.49 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 163
USD 2900.00
(Single User License)
The global Bifidobacterium Longum Subsp. Infantis M-63 market is projected to grow from US$ 44.7 million in 2024 to US$ 67.7 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 190
USD 4900.00
(Single User License)
The global Bifidobacterium Longum Subsp. Infantis M-63 market size was US$ 44.7 million in 2024 and is forecast to a readjusted size of US$ 67.7 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 112
USD 4250.00
(Single User License)
The global market for Bifidobacterium Longum Subsp. Infantis M-63 was estimated to be worth US$ 44.7 million in 2024 and is forecast to a readjusted size of US$ 67.7 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 159
USD 3950.00
(Single User License)
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
Published Date: 2024-09-11
Pages: 172
USD 4350.00
(Single User License)
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
Published Date: 2024-09-11
Pages: 193
USD 4900.00
(Single User License)
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
Published Date: 2024-09-11
Pages: 120
USD 2900.00
(Single User License)
The global Bifidobacterium Longum Subsp. Infantis M-63 market is projected to grow from US$ 47.19 million in 2025 to US$ 71.49 million by 2032, at a CAGR of 6.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 200
The global Bifidobacterium Longum Subsp. Infantis M-63 market size was US$ 47.19 million in 2025 and is forecast to reach a readjusted size of US$ 71.49 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 115
The global market for Bifidobacterium Longum Subsp. Infantis M-63 was estimated to be worth US$ 47.19 million in 2025 and is projected to reach US$ 71.49 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-01-09
Pages: 154
The global Bifidobacterium Longum Subsp. Infantis M-63 market was valued at US$ 47.19 million in 2025 and is anticipated to reach US$ 71.49 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-01-09
Pages: 163
The global Bifidobacterium Longum Subsp. Infantis M-63 market is projected to grow from US$ 44.7 million in 2024 to US$ 67.7 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 190
The global Bifidobacterium Longum Subsp. Infantis M-63 market size was US$ 44.7 million in 2024 and is forecast to a readjusted size of US$ 67.7 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 112
The global market for Bifidobacterium Longum Subsp. Infantis M-63 was estimated to be worth US$ 44.7 million in 2024 and is forecast to a readjusted size of US$ 67.7 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 159
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
Published: 2024-09-11
Pages: 172
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
Published: 2024-09-11
Pages: 193
Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
Published: 2024-09-11
Pages: 120
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now